Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With
KRAS
Wild-Type Advanced or Metastatic Colorectal Cancer
JAMA | June 20, 2017 | Volume: 317 | Issue: 23 | Pages: 2392
10.1001/jama.2017.7105
| PMID 28632865